USD0.000æéå€ååŒÂ  (ET)
1.53BæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
31.590å§å€
31.700é«å€
764.55Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
88.59äºæ³PER
--çŽè¿12ã¶æé
åœ
1.61%売買å転ç
31.640忥çµå€
31.020å®å€
16.02M売買代é
æå€±é¡æ ªäŸ¡åçç
4.22PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-2.82%ç·è³ç£å©çç
29.62052é±é«å€
0.63åºæ¥é«æ¯ç%
-20.18MçŽå©ç
47.55Mæ ªåŒæ°
-0.06221æ ªåœããå©çïŒEPSïŒ
2.00ããŒã¿å€
-3.09%èªå·±è³æ¬å©çç
17.86052é±å®å€
2.15%æ¯ãå¹
63.31%ç²å©çç
1.53BæäŸ¡ç·é¡
5.27ãªã¹ã¯ãªã¿ãŒã³
2.63%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
BioLife Solutions Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»çæ©åš & å忥çã§ã®é äœã¯199äž11äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯31.12ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯è¯å¥œã§ããã¡ã³ãã¡ã³ã¿ã«ãºãåªããŠããŸãããããã¯ãã«ã«ã¯çŸåšã®ãã¬ã³ããè£ä»ãããã®ã§ã¯ãããŸãããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
BioLife Solutions Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
BioLife Solutions Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
BioLife Solutions Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
BioLife Solutions Inc
BLFS
9
Zimmer Biomet Holdings Inc
ZBH
31
ææšî
ææš
売ã(2)
äžç«(3)
è²·ã(2)
ç§»åå¹³å
売ã(0)
äžç«(0)
è²·ã(6)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
BioLife Solutions Incã®äŒæ¥æ
å ±î
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Companyâs ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
äŒæ¥ã³ãŒãBLFS
äŒæ¥åBioLife Solutions Inc
æé«çµå¶è²¬ä»»è
ãCEOãDe Greef (Roderick)
ãŠã§ããµã€ãhttps://www.biolifesolutions.com/
æ ªäž»çµ±èšî
ãããã質å
BioLife Solutions IncïŒBLFSïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îBioLife Solutions IncïŒBLFSïŒã®çŸåšã®æ ªäŸ¡ã¯31.28ã§ãã
BioLife Solutions Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îBioLife Solutions Incã®ãã£ãã«ãŒã·ã³ãã«ã¯BLFSã§ãã
BioLife Solutions Incã®52é±é«å€ã¯ãããã§ããïŒ
îBioLife Solutions Incã®52é±é«å€ã¯29.62ã§ãã
BioLife Solutions Incã®52é±å®å€ã¯ãããã§ããïŒ
îBioLife Solutions Incã®52é±å®å€ã¯17.86ã§ãã
BioLife Solutions Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îBioLife Solutions Incã®æäŸ¡ç·é¡ã¯1.53Bã§ãã
BioLife Solutions Inc (BLFS) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãBioLife Solutions IncïŒBLFSïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯31.12ã§ãã
BioLife Solutions Inc (BLFS) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îBioLife Solutions IncïŒBLFSïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.10ã§ãã